查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球数字医疗市场 - 2023-2030
市场调查报告书
商品编码
1297773

全球数字医疗市场 - 2023-2030

Global Digital Health Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球数字健康市场在2022年达到2232亿美元，预计到2030年将见证有利可图的增长，达到8503亿美元。在2023-2030年的预测期间，全球数字健康市场预计将呈现18.9%的复合增长率。越来越多的技术进步和新型产品的临床试验推动了数字健康市场的需求趋势。

创新技术的发展，软件和服务的进步，新更新的推出，以及需要病人监测的病人数量的增加，是推动全球数字健康市场的主要因素。

数字健康市场范围包括组件、技术和终端用户，增加了数字健康市场份额。全球数字健康市场正在扩大，原因包括不断增加的研究和开发，他们即将在各国批准的新产品也为数字健康市场的增长创造了一个积极的前景。

市场动态

不断增加的研究和开发以及新产品的推出推动了数字健康市场的增长。

尽管还没有足够的数据来支持其广泛使用，但医疗机构正慢慢开始将可穿戴技术融入病人护理中。设备与辐射健康中心（CDRH）的数字健康卓越中心（DHCoE）旨在支持负责任的数字健康创新，保护和促进公共健康，包括科学研究和伙伴关系。

通过以数字健康为中心的合作，CDRH正在促进监管科学研究，这使得FDA专家能够理解和评估与新兴数字健康技术相关的优势和风险。通过提供科学、公正和客观的专业知识，这项研究有助于保证患者和消费者使用的商品的安全或减少其危害。

政府支持和倡议的增加为制造商创造了有利可图的机会

政府支持和倡议的增加是推动数字医疗市场发展的主要因素。例如，欧盟委员会和世界卫生组织（WHO）在数字健康领域发起了一个历史性的联盟。

欧盟（EU）的数字COVID-19认证平台将于2023年6月被世卫组织采用，以建立一个全球系统，协助促进跨境流动，保障世界各地的人们免受目前和潜在的健康危险，如大流行病。世卫组织全球数字健康认证网络（GDHCN）将创建各种数字产品以促进全民健康的改善，这是其第一个基石。

该项目是在2022年11月30日特德罗斯博士和基里亚基德委员之间达成的协议之后进行的，目的是在全球健康问题上加强战略合作。它取决于世卫组织和欧盟关于数字健康的全球卫生战略。

与数字健康相关的劣势将阻碍市场的增长。

应用程序内容像其他数字信息一样容易受到数据泄露和黑客攻击。此外，一个应用程序可能会泄露用户的隐私和个人数据。此外，移动应用程序中的内容比医学期刊中的内容受到的监督要少。例如，它们在测量血压时可能会产生错误的结果。

另一方面，技术本身也带来了困难。无线连接、软件和硬件都不是没有错误的。它们可能会在虚拟测试的过程中突然停止工作。对于某些人来说，转换到技术可能会带来更大的挑战。

关于远程医疗和远程保健活动，每个州都有自己的法律和准则。同样，随着我们对技术的依赖程度越来越高，人们越来越担心细节是否安全，是否受到黑客和安全漏洞的保护。

COVID-19影响分析

COVID-19疫情和全球封锁影响了所有行业企业的财务健康。因此，美国食品和药物管理局（FDA）发布了COVID-19卫生紧急情况指南，包括协助赞助商和研究人员的一般注意事项，确保试验参与者的安全，遵循良好的临床实践（GCP），并减少对试验完整性的风险。

俄乌战争影响分析

俄罗斯-乌克兰冲突估计对全球数字医疗市场的影响不大，因为该地区的主要市场参与者数量较少。然而，在预测期内，原材料进出口的影响预计对全球数字健康市场的增长影响不大。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按组件分析
  • 按技术分类的摘要
  • 按终端用户分类
  • 按地区分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 远程监控服务需求上升
      • 政府支持和倡议的增加
    • 限制因素
      • 与数字医疗相关的劣势
    • 机会
      • 研究与开发和新产品发布的增加
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第7章：按组件分类

  • 硬件
  • 软件
  • 服务

第8章：按技术分类

  • 移动医疗
    • 可穿戴设备
      • 血糖仪
      • 脉搏血氧仪
      • 心脏监测器
      • 呼吸暂停和睡眠监测器
      • 神经系统监测仪
      • 其他
    • 应用程序
      • 健美应用
      • 医疗应用
  • 电子健康
    • 电子病历(EHR)
    • 供应商中立档案（VNA）和图片存档与通信系统（PACS）。
    • 实验室信息系统（LIS）
    • 处方解决方案
  • 远程医疗
    • 远程医疗
      • 视频咨询
      • 长期护理监测
    • 远程护理
      • 远程用药管理
      • 活动监测
  • 健康分析

第九章：按终端用户分类

  • 医疗保健供应商
  • 医疗保健消费者
  • 其他用户

第十章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
      • 亚太其他地区
  • 中东和非洲
    • 关键区域的动态

第11章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併和收购分析

第十二章 ：公司简介

  • BioTelemetry, a Philips Company
    • 公司概述
    • 产品组合和描述
    • 财务概况
    • 主要发展情况
  • Veradigm LLC
  • EClinicalWorks
  • IHealth Labs Inc
  • Athenahealth Inc.
  • AT&T
  • Honeywell International Inc.
  • Cisco Systems, Inc.
  • AdvancedMD, Inc.
  • McKesson Corporation

第十三章 ：附录

简介目录
Product Code: HCIT6461

Market Overview

The Global Digital Health Market reached US$ 223.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 850.3 billion by 2030. The Global Digital Health Market is expected to exhibit a CAGR of 18.9% during the forecast period 2023-2030. The increasing technological advancements and clinical trials for novel products drive demand for digital health market trends.

The development of innovative technologies, advancements in software and services, the launch of new updates, and an increase in a number of patients requiring patient monitoring are the main factors propelling the global market for digital health.

The Digital Health Market scope comprises components, technology and end-user, increasing the digital health market share. The global market for digital health is expanding due to factors including increasing research and development and their upcoming novel product approvals across countries are also creating a positive outlook for the digital health market growth.

Market Dynamics

Rising Research and Development and Novel Product Launches Drive the Growth of the Digital Health market.

Even though there isn't yet enough data to support its widespread use, healthcare is slowly beginning to integrate wearable technology in patient care. The Center for Devices and Radiological Health's (CDRH) Digital Health Center of Excellence (DHCoE) aims to support responsible digital health innovation and protect and promote public health, including scientific research and partnerships.

Through collaborations centered on digital health, CDRH is promoting regulatory science research, which allows FDA experts to comprehend and evaluate the advantages and risks associated with emerging digital health technologies. By offering scientific, unbiased, and objective expertise, this research helps guarantee the safety or lessen the harm related to goods used by patients and consumers.

Increased Government Support and Initiatives creates Lucrative Opportunities for Manufacturers

There are rising government support and initiatives are the major factors driving the growth of the digital health market. For instance, the European Commission and the World Health Organization (WHO) launched a historic alliance in digital health.

The European Union (EU) platform for digital COVID-19 certification will be adopted by WHO in June 2023 to create a global system that will aid in facilitating cross-border mobility and safeguarding people all over the world from present and potential health dangers, such as pandemics. The WHO Global Digital Health Certification Network (GDHCN), which will create various digital products to promote improved health for all, has this as its first cornerstone.

The project follows the 30 November 2022 deal between Dr. Tedros and Commissioner Kyriakides to increase strategic collaboration on global health concerns. It depends on the WHO and EU Global Health Strategy on Digital Health.

Disadvantages Associated with Digital Health will Hamper the Growth of the Market.

App content is vulnerable to data breaches and hackers like other digital information. Additionally, an app can divulge user data that is private and personal. Additionally, the content in mobile apps is less monitored than that found in medical journals. For instance, they might produce erroneous findings when measuring blood pressure.

On the other hand, technology itself presents difficulties. Wireless connections, software, and hardware are not error-free. They may stop working suddenly or in during the course of a virtual test. For certain individuals, converting to technology can potentially provide a greater challenge.

Regarding telemedicine and telehealth activities, each state has its own laws and guidelines. Again, there are growing worries about how secure and safeguarded details are from hackers and security breaches as we depend more heavily on technology.

COVID-19 Impact Analysis

The COVID-19 epidemic and the worldwide lockdown have affected the financial health of businesses in all industries. As a result, the U.S. Food and Drug Administration (FDA) released guidelines for the COVID-19 health emergency, including general considerations to assist sponsors and researchers, ensure trial participants' safety, follow good clinical practice (GCP), and reduce risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global digital health market, owing to the low number of key market players in this region. However, the effect of the import and export of raw materials is expected to have little influence over the Global Digital Health market growth over the forecast period.

Segment Analysis

The Global Digital Health Market is segmented based on component, technology, end user and region.

mHealth from Technology Accounts for 27.2% of Market Share Owing to Rising Utilization

Over the past year, the field of digital health has experienced tremendous growth. Electronic health, mobile health, and telehealth are all used to refer to the use of desktop and mobile technology for patient management. The phrase "mHealth," or "mobile health," implies the application of portable technologies, such as tablets and smartphones, to support medical processes.

Patients can log, save, and analyze their health data on their own mobile devices using mHealth services. These programs aid in increasing the effectiveness of the dissemination of medical information. Apps for mobile health may be useful for researchers, patients, and healthcare professionals.

Additionally, mobile health-tracking apps are becoming more widely used daily. There are more than 318,000 health applications available for download. GoogleFit, Fitbit, and Apple Heart Study are a few well-known mHealth app examples.

Geographical Analysis

North America Accounted for Approximately 45.3% of the Market Share Owing to the Strong Presence of Major Players and Rising Technological Advancements

Manufacturers have chances to expand their operations in this region because of the rising demand for digital health for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of digital health, increasing demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for novel technologies.

The market will grow as new components or technology for healthcare emerge. Rising technological developments, governmental approvals, and introducing new products all contribute to growth. People are becoming more aware of novel technologies and apps for digital healthcare, leading to the market expansion in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the digital health market include: BioTelemetry, a Philips Company, EClinicalWorks, Veradigm LLC, IHealth Labs Inc, AT&T, Athenahealth Inc., Honeywell International Inc., AdvancedMD, Inc., Cisco Systems, Inc. and McKesson Corporation among others.

Why Purchase the Report?

  • To visualize the Global Digital Health Market segmentation based on component, technology, end user and region, and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous digital health market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Digital Health Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Technology
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Remote Monitoring Services Demand
      • 4.1.1.2. Increased Government Support and Initiatives
    • 4.1.2. Restraints
      • 4.1.2.1. Disadvantages Associated with Digital Health
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Research and Development and Novel Product Launches
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Hardware *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Software
  • 7.4. Services

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. mHealth *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Wearables
      • 8.2.3.1. Blood Glucose Meter
      • 8.2.3.2. Pulse Oximetry
      • 8.2.3.3. Cardiac Monitors
      • 8.2.3.4. Apnea & Sleep Monitors
      • 8.2.3.5. Neurological Monitors
      • 8.2.3.6. Others
    • 8.2.4. Apps
      • 8.2.4.1. Fitness Apps
      • 8.2.4.2. Medical Apps
  • 8.3. eHealth
    • 8.3.1. Electronic Health Records (EHR)
    • 8.3.2. Vendor Neutral Archive (VNA) and Picture Archiving & Communications Systems (PACS)
    • 8.3.3. Laboratory Information Systems (LIS)
    • 8.3.4. Prescribing Solutions
  • 8.4. Telehealthcare
    • 8.4.1. Telehealth
      • 8.4.1.1. Video Consultation
      • 8.4.1.2. LTC Monitoring
    • 8.4.2. Telecare
      • 8.4.2.1. Remote Medication Management
      • 8.4.2.2. Activity Monitoring
  • 8.5. Health Analytics

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Healthcare Providers *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Healthcare Consumers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. BioTelemetry, a Philips Company *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Veradigm LLC
  • 12.3. EClinicalWorks
  • 12.4. IHealth Labs Inc
  • 12.5. Athenahealth Inc.
  • 12.6. AT&T
  • 12.7. Honeywell International Inc.
  • 12.8. Cisco Systems, Inc.
  • 12.9. AdvancedMD, Inc.
  • 12.10. McKesson Corporation

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us